Protective Effects of Estrogen via Nanoparticle Delivery to Attenuate Myelin Loss and Neuronal Death after Spinal Cord Injury

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Neurochemical Research

• Publication date

  2021-07-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11064-021-03401-2PMID 34269965PMCID PMC9723545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Review of operative considerations in spinal cord stem cell therapy

  2021cited by this paper
• Exosomal miR-155 from M1-polarized macrophages promotes EndoMT and impairs mitochondrial function via activating NF-κB signaling pathway in vascular endothelial cells after traumatic spinal cord injury

  2021cited by this paper
• Nanoparticle-Based Estrogen Delivery to Spinal Cord Injury Site Reduces Local Parenchymal Destruction and Improves Functional Recovery

  2020cited by this paper
• Reactive Astrogliosis: Implications in Spinal Cord Injury Progression and Therapy

  2020cited by this paper
• Moving beyond the glial scar for spinal cord repair

  2019cited by this paper
• Autophagy‐dependent crosstalk between GILT and PAX‐3 influences radiation sensitivity of human melanoma cells

  2018cited by this paper
• Astrocyte reactivity and astrogliosis after spinal cord injury.

  2018cited by this paper
• Targeting Enolase in Reducing Secondary Damage in Acute Spinal Cord Injury in Rats

  2017cited by this paper
• The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age-Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults

  2016cited by this paper
• Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.

  2016cited by this paper
• 2-Methoxyestradiol, an endogenous 17β-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism.

  2016cited by this paper
• Vimentin coordinates fibroblast proliferation and keratinocyte differentiation in wound healing via TGF-β–Slug signaling

  2016cited by this paper
• Administration of low dose estrogen attenuates gliosis and protects neurons in acute spinal cord injury in rats

  2016cited by this paper
• ROS homeostasis and metabolism: a dangerous liason in cancer cells

  2016cited by this paper
• The Role of Oxidative Stress in Neurodegenerative Diseases

  2015cited by this paper
• Elevation of c-MYC Disrupts HLA Class II–Mediated Immune Recognition of Human B Cell Tumors

  2015cited by this paper
• Effect of low temperatures on BAX and BCL2 proteins in rats with spinal cord ischemia reperfusion injury.

  2015cited by this paper
• Does being female provide a neuroprotective advantage following spinal cord injury?

  2015cited by this paper
• Nanoparticle Estrogen in Rat Spinal Cord Injury Elicits Rapid Anti-Inflammatory Effects in Plasma, Cerebrospinal Fluid, and Tissue

  2015cited by this paper
• Vimentin regulates activation of the NLRP3 inflammasome

  2015cited by this paper
• Microgravity control of autophagy modulates osteoclastogenesis.

  2014cited by this paper
• Tamoxifen and estradiol improved locomotor function and increased spared tissue in rats after spinal cord injury: their antioxidant effect and role of estrogen receptor alpha.

  2014cited by this paper
• Vimentin knockdown decreases corneal opacity.

  2014cited by this paper
• Function of microglia and macrophages in secondary damage after spinal cord injury

  2014cited by this paper
• Injury timing alters metabolic, inflammatory and functional outcomes following repeated mild traumatic brain injury.

  2014cited by this paper
• Functional regeneration beyond the glial scar.

  2014cited by this paper
• Chondroitin Sulfate Proteoglycans in the Nervous System: Inhibitors to Repair

  2014cited by this paper
• Sex steroids and neuroprotection in spinal cord injury: a review of preclinical investigations.

  2014cited by this paper
• Evaluation of genistein ability to modulate CTGF mRNA/protein expression, genes expression of TGFβ isoforms and expression of selected genes regulating cell cycle in keloid fibroblasts in vitro.

  2014cited by this paper
• Anti-microRNA-378a Enhances Wound Healing Process by Upregulating Integrin Beta-3 and Vimentin

  2014cited by this paper
• Survey of Cervical Spine Research Society Members on the Use of High-Dose Steroids for Acute Spinal Cord Injuries

  2014cited by this paper
• Contribution of estrogen receptors alpha and beta in the brain response to traumatic brain injury.

  2013cited by this paper
• Perivascular Fibroblasts Form the Fibrotic Scar after Contusive Spinal Cord Injury

  2013cited by this paper
• Effects of estrogen, estrogen/progesteron combination and genistein treatments on oxidant/antioxidant status in the brain of ovariectomized rats.

  2013cited by this paper
• 17β-Estradiol Confers Protection after Traumatic Brain Injury in the Rat and Involves Activation of G Protein-Coupled Estrogen Receptor 1

  2013cited by this paper
• Inhibition of transforming growth factor beta-activated kinase 1 confers neuroprotection after traumatic brain injury in rats.

  2013cited by this paper
• Antioxidant therapies in traumatic brain and spinal cord injury.

  2012cited by this paper
• Understanding the role of stromal fibroblasts in cancer progression

  2012cited by this paper
• Estradiol modulates post-ischemic cerebral vascular remodeling and improves long-term functional outcome in a rat model of stroke.

  2012cited by this paper
• Estrone Is Neuroprotective in Rats after Traumatic Brain Injury

  2012cited by this paper
• Steroids for acute spinal cord injury.

  2012cited by this paper
• Reactive Astrogliosis after Spinal Cord Injury—Beneficial and Detrimental Effects

  2012cited by this paper
• Postinjury administration of 17β‐estradiol induces protection in the gray and white matter with associated functional recovery after cervical spinal cord injury in male rats

  2012cited by this paper
• 17β-Estradiol inhibits apoptotic cell death of oligodendrocytes by inhibiting RhoA-JNK3 activation after spinal cord injury.

  2012cited by this paper
• Sex Steroids Control Neuroinflammatory Processes in the Brain: Relevance for Acute Ischaemia and Degenerative Demyelination

  2012cited by this paper
• Clinical trials in spinal cord injury: lessons learned on the path to translation. The 2011 International Spinal Cord Society Sir Ludwig Guttmann Lecture

  2012cited by this paper
• The Use of Methylprednisolone in Acute Spinal Cord Injury: A Review of the Evidence, Controversies, and Recommendations

  2012cited by this paper
• Polyethylene Glycol-Coated (Pegylated) Liposomal Doxorubicin

  2012cited by this paper
• Post-ischemic estradiol treatment reduced glial response and triggers distinct cortical and hippocampal signaling in a rat model of cerebral ischemia

  2012cited by this paper
• Mechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrol

  2012cited by this paper
• Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.

  2011cited by this paper
• Low dose Estrogen Prevents Neuronal Degeneration and Microglial Reactivity in an Acute Model of Spinal Cord Injury: Effect of Dosing, Route of Administration, and Therapy Delay

  2011cited by this paper
• Spinal cord injury: From inflammation to glial scar

  2011cited by this paper
• Oxidative Stress in Neurodegeneration

  2011cited by this paper
• Enhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1.

  2011cited by this paper
• Effect of estrogens on blood glutamate levels in relation to neurological outcome after TBI in male rats

  2011cited by this paper
• Oxidative stress in spinal cord injury and antioxidant-based intervention

  2011cited by this paper
• Antibody-directed targeting of lysostaphin adsorbed onto polylactide nanoparticles increases its antimicrobial activity against S. aureus in vitro

  2011cited by this paper
• Protein–nanoparticle conjugates as potential therapeutic agents for the treatment of hyperlipidemia

  2010cited by this paper
• Neuroprotective efficacy of estrogen in experimental spinal cord injury in rats

  2010cited by this paper
• Effect of Endogenous Androgens on 17β-Estradiol-Mediated Protection after Spinal Cord Injury in Male Rats

  2010cited by this paper
• Role of estrogen receptors in pro-oxidative and anti-oxidative actions of estrogens: a perspective.

  2010cited by this paper
• Postinjury estrogen treatment of chronic spinal cord injury improves locomotor function in rats

  2010cited by this paper
• Estradiol rescues neurons from global ischemia-induced cell death: multiple cellular pathways of neuroprotection.

  2009cited by this paper
• Estrogen Attenuates Ischemic Oxidative Damage via an Estrogen Receptor α-Mediated Inhibition of NADPH Oxidase Activation

  2009cited by this paper
• Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma

  2008cited by this paper
• Effect of 17beta-estradiol on functional outcome, release of cytokines, astrocyte reactivity and inflammatory spreading after spinal cord injury in male rats.

  2008cited by this paper
• Spatial distribution and acute anti-inflammatory effects of Methylprednisolone after sustained local delivery to the contused spinal cord.

  2008cited by this paper
• CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure.

  2008cited by this paper
• Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells.

  2007cited by this paper
• Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells

  2007cited by this paper
• Free radicals and antioxidants in normal physiological functions and human disease.

  2007cited by this paper
• EFFECT OF 17&bgr;-ESTRADIOL ON SIGNAL TRANSDUCTION PATHWAYS AND SECONDARY DAMAGE IN EXPERIMENTAL SPINAL CORD TRAUMA

  2007cited by this paper
• Methylprednisolone and Indomethacin Inhibit Oxidative Stress Mediated Apoptosis in Rat C6 Glioblastoma Cells

  2007cited by this paper
• MAP kinase regulation of IP10/CXCL10 chemokine gene expression in microglial cells.

  2006cited by this paper
• Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats

  2005cited by this paper
• Neuroprotective Anti-Apoptosis Effect of Estrogens in Traumatic Brain Injury

  2005cited by this paper
• Reactive Oxygen Species Promote TNF -Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases

  2005cited by this paper
• Systemic Administration of 17β-Estradiol Reduces Apoptotic Cell Death and Improves Functional Recovery following Traumatic Spinal Cord Injury in Rats

  2004cited by this paper
• Oxidative stress in neurodegeneration: cause or consequence?

  2004cited by this paper
• Systemic administration of 17beta-estradiol reduces apoptotic cell death and improves functional recovery following traumatic spinal cord injury in rats.

  2004cited by this paper
• Estrogen as a Multi-Active Neuroprotective Agent in Traumatic Injuries

  2004cited by this paper
• Cutting Edge: Induction of the Antigen-Processing Enzyme IFN-γ-Inducible Lysosomal Thiol Reductase in Melanoma Cells Is STAT1-Dependent but CIITA-Independent1

  2004cited by this paper
• Discovery of estrogen receptor α target genes and response elements in breast tumor cells

  2004cited by this paper
• Estrogen as a Neuroprotective Agent in the Treatment of Spinal Cord Injury

  2003cited by this paper
• Drug development in spinal cord injury: what is the FDA looking for?

  2003cited by this paper
• Neuroprotection by Estrogen in Animal Models of Global and Focal Ischemia

  2003cited by this paper
• Absence of γ-Interferon–inducible Lysosomal Thiol Reductase in Melanomas Disrupts T Cell Recognition of Select Immunodominant Epitopes

  2002cited by this paper
• Steroids for acute spinal cord injury.

  2002cited by this paper
• Oral contraceptives and venous thromboembolism: a five-year national case-control study.

  2002cited by this paper
• The astrocyte/meningeal cell interface – a barrier to successful nerve regeneration?

  2001cited by this paper
• Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours.

  1997cited by this paper
• Therapeutic Model for Experimental Spinal Cord Injury in the Rat: I. Mortality and Motor Deficit

  1987cited by this paper

• Focal Estrogen Therapy in Male Rats Promotes Neuronal Survival and Reduces Denervation Atrophy After Spinal Cord Injury via Modulation of β-Catenin and NF-κB

  2026cites this paper
• Calpain-2 Regulates Kinesin and Dynein Dysfunction in Neurotoxin-Induced Motoneuron Injury

  2026cites this paper
• Neuroprotective Effects of Calpain Inhibition in Parkinson’s Disease: Insights from Cellular and Murine Models

  2025cites this paper
• Nanomaterial-based therapeutic strategies for spinal cord injury repair: harnessing multifunctionality to overcome pathophysiological challenges.

  2025cites this paper
• Microglial estrogen receptor 1 signal designates sexual dimorphism of AQP4 antibody-induced neuroinflammation and demyelination.

  2025cites this paper
• A Review of the Potential Use of Antioxidants in Spinal Cord Injuries

  2025cites this paper
• Nanotherapeutics for Alleviating Anesthesia‐Associated Complications

  2024cites this paper
• Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases

  2024cites this paper
• Induction of Neural Differentiation and Protection by a Novel Slow-Release Nanoparticle Estrogen Construct in a Rat Model of Spinal Cord Injury

  2024cites this paper
• Revisiting the Emerging Role of Light-Based Therapies in the Management of Spinal Cord Injuries

  2024cites this paper
• Targeted Therapy of Spinal Cord Injury: Inhibition of Apoptosis Is a Promising Therapeutic Strategy

  2023cites this paper
• Pharmacological interventions targeting the microcirculation following traumatic spinal cord injury

  2023cites this paper
• The NF-κB Pathway: a Focus on Inflammatory Responses in Spinal Cord Injury

  2023cites this paper
• A comprehensive look at the psychoneuroimmunoendocrinology of spinal cord injury and its progression: mechanisms and clinical opportunities

  2023cites this paper
• Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease

  2022cites this paper
• Recent advances in nanomaterials for the treatment of spinal cord injury

  2022cites this paper
• Pathophysiology and Therapeutic Approaches for Spinal Cord Injury

  2022cites this paper
• The neuroprotective effects of estrogen and estrogenic compounds in spinal cord injury

  2022influential citation
• Combination Therapy Using Nanomaterials and Stem Cells to Treat Spinal Cord Injuries.

  2022cites this paper
• The ROCK inhibitor Y-27632 ameliorates blood-spinal cord barrier disruption by reducing tight junction protein degradation via the MYPT1-MLC2 pathway after spinal cord injury in rats.

  2021cites this paper